Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Funding
Sign In Sign Up
Night Mode
PARP Inhibitors and the Ovarian Cancer Therapeutics Market
The ovarian cancer diagnostics and therapeutics market is evolving toward liquid biopsy, AI-assisted diagnostics, and global expansion. These trends will shape growth and determine how ovarian cancer is detected and treated over the coming decade. Liquid biopsy is a major theme. Blood-based tests that detect circulating tumour DNA are being developed for early detection and monitoring....
0 Comments ·0 Shares ·31 Views ·0 Reviews
Please log in to like, share and comment!